Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eye drug levels checked in both eyes for macular disease

NCT ID NCT06591598

First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 30 times

Summary

This study looked at how much of the eye medicine aflibercept enters the bloodstream when given as injections into both eyes. It included 51 adults with diabetic macular edema or age-related macular degeneration. The goal was to measure drug levels in the blood, not to test if the treatment works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Axon Clinical, s.r.o.

    Prague, 150 00, Czechia

  • Budapest Retina Associates

    Budapest, 1133, Hungary

  • Debreceni Egyetem Klinikai Kozpont

    Debrecen, 4032, Hungary

  • Fakultna nemocnica s poliklinikou Zilina

    Žilina, 012 07, Slovakia

  • Fakultní nemocnice Královské Vinohrady - Urologická klinikay

    Prague, 10034, Czechia

  • Univerzitna nemocnica Bratislava, Nem. Sv. Cyrila a Metoda

    Bratislava, 851 07, Slovakia

Conditions

Explore the condition pages connected to this study.